A carregar...

Pulmonary Complications of Azanucleoside Therapy in Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia

Our primary aim was to identify potential risk factors and clinical outcome of azanucleoside induced pulmonary complications in patients with myelodysplastic syndrome (MDS) and Acute Myelogenous Leukemia (AML). We present an 89-year-old female with MDS derived AML who developed fatigability, hypoxem...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Case Rep Hematol
Main Authors: Molina, Manuel, Yellapragada, Sarvari, Mims, Martha, Rahman, Effie, Rivero, Gustavo
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4698523/
https://ncbi.nlm.nih.gov/pubmed/26798526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/357461
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!